While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Not all companies are created equal, and StockStory is here to surface the ones with real upside. That said, here is one cash-producing company that reinvests wisely to drive long-term success and two that may struggle to keep up.
Two Stocks to Sell:
Apogee (APOG)
Trailing 12-Month Free Cash Flow Margin: 4.7%
Involved in the design of the Apple Store on Fifth Avenue in New York City, Apogee (NASDAQ: APOG) sells architectural products and services such as high-performance glass for commercial buildings.
Why Do We Avoid APOG?
- Annual sales declines of 2.4% for the past two years show its products and services struggled to connect with the market during this cycle
- Anticipated sales growth of 3% for the next year implies demand will be shaky
- Flat earnings per share over the last two years lagged its peers
Apogee’s stock price of $44.34 implies a valuation ratio of 10.6x forward P/E. To fully understand why you should be careful with APOG, check out our full research report (it’s free).
Option Care Health (OPCH)
Trailing 12-Month Free Cash Flow Margin: 4.5%
With a nationwide network of 177 locations serving 43 states and a team of over 4,500 clinicians, Option Care Health (NASDAQ: OPCH) is the largest independent provider of home and alternate site infusion services, delivering medications and clinical support to patients across the United States.
Why Are We Hesitant About OPCH?
Option Care Health is trading at $28.20 per share, or 15.6x forward P/E. Read our free research report to see why you should think twice about including OPCH in your portfolio.
One Stock to Watch:
HubSpot (HUBS)
Trailing 12-Month Free Cash Flow Margin: 18.2%
Born from the idea that traditional interruptive marketing was becoming less effective, HubSpot (NYSE: HUBS) provides an integrated platform that helps businesses attract, engage, and manage customer relationships through marketing, sales, service, and content management tools.
Why Do We Like HUBS?
- Average billings growth of 21.3% over the last year enhances its liquidity and shows there is steady demand for its products
- Sales outlook for the upcoming 12 months implies the business will stay on its desirable three-year growth trajectory
- Software is difficult to replicate at scale and results in a stellar gross margin of 84.6%
At $459.50 per share, HubSpot trades at 7.2x forward price-to-sales. Is now a good time to buy? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.
The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
